Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quadrivalent HPV Vaccine to Prevent Anal HPV Infection in HIV-Infected Men and Women
NCT01461096Phase 3Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Mar 2012
- Primary completion
- Dec 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 3
01
Overview
A Phase 3 trial of quadrivalent human papillomavirus vaccine in anal human papillomavirus infection, sponsored by National Institute of Allergy and Infectious Diseases. Started Mar 2012; status: completed.
02
Drugs
quadrivalent human papillomavirus vaccine
03
Conditions
anal human papillomavirus infection
Beyond the preview
Go deeper on NCT01461096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01461096.